News

Abiraterone Acetate Tablets exported to US

ABOUT US

News

Abiraterone Acetate Tablets exported to US

Release time：

2020-01-20

Qilu Pharmaceutical announced Abiraterone Acetate Tablets was exported to the US on January 20, 2020. Up to now, Qilu has exported fourteen products to US and among them, ten products are the injectables.

The total volume of finished formulations exported to US is over 100 million units in 2019, increasing 160% compared with 2018. Several products ranked top 3 in US market.

Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China

The first Avastin(Bevacizumab) Biosimilar approval in China granted by NMPA

Related News

Qilu Pharmaceutical ranks No.3 in the list of "Top 100 Enterprises in Chinese Pharmaceutical industry”

2024-09-30

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”